Skip to main content

View full-text article in PMC

. Author manuscript; available in PMC: 2012 Mar 18.

Published in final edited form as: Kidney Int. 2010 Dec 22;79(6):678–685. doi: 10.1038/ki.2010.485

Table 2.

QOL assessment of children with steroid-resistant FSGS compared with healthy and ESKD controls

	FSGS CT			ESKD^a			Healthy^b
	N	Mean	s.d.	N	Mean	s.d.	N	Mean	s.d.
Physical functioning
Parent^c,^d	94	73.5	26.0	186	68.24	24.09	9430	84.48	19.51
Child^c	80	77.7	19.1	190	74.97	19.37	5480	87.53	13.50
Emotional functioning
Parent^c	94	66.2	22.1	188	68.93	21.13	9430	81.31	16.50
Child^c	80	71.0	19.0	190	72.53	20.80	5480	79.33	18.15
Social functioning
Parent^d	94	81.1	20.6	188	70.43	23.77	9430	83.70	19.43
Child^d	80	85.3	16.5	189	77.80	20.96	5480	85.15	16.76
School functioning
Parent^c,^d	89	70.0	20.8	181	59.16	25.04	9430	78.83	19.59
Child^c	80	69.8	17.7	188	63.57	22.18	5480	81.12	16.45
Total score
Parent^c,^d	94	72.7	17.8	186	67.02	19.84	9430	82.70	15.40
Child^c	80	76.0	13.3	190	72.53	16.16	5480	83.84	12.65

Abbreviations: ESKD, end-stage kidney disease; FSGS CT, Focal Segmental Glomerulosclerosis Clinical Trial; QOL, quality of life.

^a

Goldstein, 2008.²¹

^b

Varni, 2007.²⁰

^c

FSGS <Healthy, P=0.00005 to P<0.0000.

^d

FSGS >ESKD, P=0.05–0.00005.